newsfilter
← Latest News
Business Wire·

ImmunoGen Announces Departure of Anna Berkenblit, Chief Medical Officer

ImmunoGen, Inc. (NASDAQ:IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Anna Berkenblit, MD, Senior Vice President and Chief Medical Officer,